Author:
Lingaraju Gejjalagere S.,Balaji Kyathegowdanadoddi S.,Jayarama Shankar,Anil Seegehalli M.,Kiran Kuppalli R.,Sadashiva Maralinganadoddi P.
Reference53 articles.
1. (a) Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics, CA: Cancer J Clin. 2011;61(2):69???90;
2. (b) World Health Organization, Global status report on noncommunicable diseases, 2014.
3. Molecular mechanisms of drug resistance;Longley;J Pathol,2005
4. Intratumor heterogeneity: evolution through space and time;Swanton;Cancer Res,2012
5. Cancer drug resistance: an evolving paradigm;Holohan;Nat Rev Cancer,2013
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, characterization, DFT, and in-Silico analysis of isoxazole-thiazolidinone hybrids: Reactivity and anticancer potential assessed through pharmacological network, molecular dynamics, molecular docking, and ADMET analysis;Journal of Molecular Structure;2025-08
2. Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate inhibits the malignant biological behaviors of colorectal cancer by restricting the phosphorylation and nuclear translocation of STAT3;Experimental Cell Research;2025-02
3. Schiff Base Moiety Could be a Possible Inhibitor of Mutated Nrf2/KEAP1 Associated Cancer;Novelties in Schiff Bases;2024-08-28
4. 3,3’-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration;PLOS ONE;2024-05-22
5. Synthesis and anticancer activity of novel coumarin-stilbene hybrids with different hydrocarbon chains as linkers;Medicinal Chemistry Research;2024-04-05